HPQ vs MBRX · P/E 8.6, rev $44.52B vs $8.2M cap
HP Inc (HPQ) versus Moleculin Biotech Inc (MBRX) — a side-by-side from cached financials, not a winner call.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Latest reported MBRX revenue for 2026-06-30 was $0. Net income was -$20.5M. MBRX currently screens at market cap $8.2M.
HPQ currently screens at market cap $21.20B and trailing P/E 8.6. MBRX currently screens at market cap $8.2M.
Not investment advice. Open the HPQ and MBRX stock pages for the full models.
Not investment advice.